Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

More On ESALY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Eisai Co., Ltd. (ESALY)

-Other OTC
42.38 Down 0.65(1.52%) Jul 31, 3:45PM EDT
Prev Close:43.03
Open:42.38
Bid:N/A
Ask:N/A
1y Target Est:36.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:42.38 - 42.38
52wk Range:36.55 - 43.03
Volume:331
Avg Vol (3m):1,364
Market Cap:12.09B
P/E (ttm):37.60
EPS (ttm):1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):33.90
P/S (ttm):2.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-15) :1.13
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):4.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eisai Co., Ltd. manufactures and sells pharmaceutical products worldwide. The company offers oncology-related products, such as Halaven, an anticancer agent; Aloxi, an antiemetic agent; Dacogen, a DNA methylation inhibitor; and Fragmin, an injecta... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback